Marion McCourt's most recent trade in Regeneron Pharmaceuticals, Inc. was a trade of 759 Common Stock done at an average price of $730.8 . Disclosure was reported to the exchange on Dec. 16, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Regeneron Pharma | Marion McCourt | EVP Commercial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 730.81 per share. | 16 Dec 2024 | 759 | 14,230 (0%) | 0% | 730.8 | 554,685 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2024 | 8,981 | 8,981 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2024 | 2,332 | 15,263 (0%) | 0% | 0 | Common Stock | |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 787.00 per share. | 06 Dec 2024 | 274 | 14,989 (0%) | 0% | 787 | 215,638 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2024 | 1,000 | 6,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 381.40 per share. | 01 Nov 2024 | 1,000 | 13,931 (0%) | 0% | 381.4 | 381,400 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Sale of securities on an exchange or to another person at price $ 844.61 per share. | 01 Nov 2024 | 1,000 | 12,931 (0%) | 0% | 844.6 | 844,610 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2024 | 1,000 | 7,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Sale of securities on an exchange or to another person at price $ 1054.06 per share. | 01 Oct 2024 | 1,000 | 12,931 (0%) | 0% | 1054.1 | 1,054,060 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 381.40 per share. | 01 Oct 2024 | 1,000 | 13,931 (0%) | 0% | 381.4 | 381,400 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Sale of securities on an exchange or to another person at price $ 1178.73 per share. | 03 Sep 2024 | 1,000 | 12,931 (0%) | 0% | 1178.7 | 1,178,730 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2024 | 1,000 | 8,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 381.40 per share. | 03 Sep 2024 | 1,000 | 13,931 (0%) | 0% | 381.4 | 381,400 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Sale of securities on an exchange or to another person at price $ 1060.86 per share. | 01 Aug 2024 | 1,137 | 12,931 (0%) | 0% | 1060.9 | 1,206,198 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 372.46 per share. | 01 Aug 2024 | 1,137 | 14,068 (0%) | 0% | 372.5 | 423,487 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2024 | 1,137 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Sale of securities on an exchange or to another person at price $ 1047.11 per share. | 01 Jul 2024 | 1,137 | 12,931 (0%) | 0% | 1047.1 | 1,190,564 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2024 | 1,137 | 1,137 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 372.46 per share. | 01 Jul 2024 | 1,137 | 14,068 (0%) | 0% | 372.5 | 423,487 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Sale of securities on an exchange or to another person at price $ 980.16 per share. | 03 Jun 2024 | 1,138 | 12,931 (0%) | 0% | 980.2 | 1,115,422 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 1,138 | 2,274 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 372.46 per share. | 03 Jun 2024 | 1,138 | 14,069 (0%) | 0% | 372.5 | 423,859 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Sale of securities on an exchange or to another person at price $ 889.41 per share. | 01 May 2024 | 250 | 12,931 (0%) | 0% | 889.4 | 222,353 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Sale of securities on an exchange or to another person at price $ 964.73 per share. | 01 Apr 2024 | 250 | 13,181 (0%) | 0% | 964.7 | 241,183 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Sale of securities on an exchange or to another person at price $ 967.50 per share. | 01 Mar 2024 | 358 | 13,431 (0%) | 0% | 967.5 | 346,365 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Sale of securities on an exchange or to another person at price $ 934.71 per share. | 05 Feb 2024 | 1,000 | 13,789 (0%) | 0% | 934.7 | 934,710 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Sale of securities on an exchange or to another person at price $ 945.61 per share. | 01 Feb 2024 | 273 | 14,789 (0%) | 0% | 945.6 | 258,152 | Common Stock |
| Regeneron Pharma | McCourt Marion | EVP Commercial | Sale of securities on an exchange or to another person at price $ 873.91 per share. | 02 Jan 2024 | 274 | 15,062 (0%) | 0% | 873.9 | 239,451 | Common Stock |
| Regeneron Pharma | McCourt Marion | EVP Commercial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 856.71 per share. | 12 Dec 2023 | 5,105 | 15,336 (0%) | 0% | 856.7 | 4,373,505 | Common Stock |
| Regeneron Pharma | McCourt Marion | EVP Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2023 | 7,649 | 7,649 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | McCourt Marion | EVP Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2023 | 2,133 | 21,084 (0%) | 0% | 0 | Common Stock | |
| Regeneron Pharma | McCourt Marion | EVP Commercial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 843.79 per share. | 08 Dec 2023 | 852 | 18,951 (0%) | 0% | 843.8 | 718,909 | Common Stock |
| Regeneron Pharma | McCourt Marion | EVP Commercial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 844.09 per share. | 08 Dec 2023 | 373 | 20,441 (0%) | 0% | 844.1 | 314,846 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Sale of securities on an exchange or to another person at price $ 838.44 per share. | 08 Dec 2023 | 270 | 20,814 (0%) | 0% | 838.4 | 226,379 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Sale of securities on an exchange or to another person at price $ 744.66 per share. | 01 Aug 2023 | 250 | 20,053 (0%) | 0% | 744.7 | 186,165 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Sale of securities on an exchange or to another person at price $ 710.09 per share. | 03 Jul 2023 | 250 | 20,303 (0%) | 0% | 710.1 | 177,523 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Sale of securities on an exchange or to another person at price $ 736.00 per share. | 01 Jun 2023 | 250 | 20,553 (0%) | 0% | 736 | 184,000 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 372.46 per share. | 03 Apr 2023 | 1,100 | 21,903 (0%) | 0% | 372.5 | 409,706 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2023 | 1,100 | 4,450 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Sale of securities on an exchange or to another person at price $ 818.80 per share. | 03 Apr 2023 | 1,100 | 20,803 (0%) | 0% | 818.8 | 900,680 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 372.46 per share. | 01 Mar 2023 | 1,100 | 21,903 (0%) | 0% | 372.5 | 409,706 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 1,100 | 5,550 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Sale of securities on an exchange or to another person at price $ 759.89 per share. | 01 Mar 2023 | 1,100 | 20,803 (0%) | 0% | 759.9 | 835,879 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 751.78 per share. | 12 Feb 2023 | 1,276 | 20,803 (0%) | 0% | 751.8 | 959,271 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 372.46 per share. | 07 Feb 2023 | 1,000 | 23,079 (0%) | 0% | 372.5 | 372,460 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2023 | 1,000 | 6,650 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Sale of securities on an exchange or to another person at price $ 769.04 per share. | 07 Feb 2023 | 1,000 | 22,079 (0%) | 0% | 769.0 | 769,040 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 372.46 per share. | 01 Feb 2023 | 1,100 | 23,179 (0%) | 0% | 372.5 | 409,706 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Sale of securities on an exchange or to another person at price $ 752.19 per share. | 01 Feb 2023 | 1,100 | 22,079 (0%) | 0% | 752.2 | 827,409 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 1,100 | 7,650 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2023 | 1,100 | 8,750 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Sale of securities on an exchange or to another person at price $ 721.86 per share. | 03 Jan 2023 | 1,100 | 22,079 (0%) | 0% | 721.9 | 794,046 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 372.46 per share. | 03 Jan 2023 | 1,100 | 23,179 (0%) | 0% | 372.5 | 409,706 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2022 | 10,971 | 10,971 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2022 | 2,973 | 22,079 (0%) | 0% | 0 | Common Stock | |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 753.28 per share. | 09 Dec 2022 | 274 | 19,370 (0%) | 0% | 753.3 | 206,399 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Sale of securities on an exchange or to another person at price $ 730.17 per share. | 09 Dec 2022 | 264 | 19,106 (0%) | 0% | 730.2 | 192,765 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Sale of securities on an exchange or to another person at price $ 756.19 per share. | 01 Dec 2022 | 1,100 | 19,644 (0%) | 0% | 756.2 | 831,809 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 372.46 per share. | 01 Dec 2022 | 1,100 | 20,744 (0%) | 0% | 372.5 | 409,706 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 1,100 | 9,850 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 372.46 per share. | 04 Nov 2022 | 1,000 | 20,644 (0%) | 0% | 372.5 | 372,460 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2022 | 1,000 | 10,950 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Sale of securities on an exchange or to another person at price $ 727.82 per share. | 04 Nov 2022 | 1,000 | 19,644 (0%) | 0% | 727.8 | 727,820 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Sale of securities on an exchange or to another person at price $ 750.00 per share. | 01 Nov 2022 | 1,100 | 19,644 (0%) | 0% | 750 | 825,000 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2022 | 1,100 | 11,950 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 372.46 per share. | 01 Nov 2022 | 1,100 | 20,744 (0%) | 0% | 372.5 | 409,706 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 600 | 13,050 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Sale of securities on an exchange or to another person at price $ 705.39 per share. | 03 Oct 2022 | 600 | 19,644 (0%) | 0% | 705.4 | 423,234 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 372.46 per share. | 03 Oct 2022 | 600 | 20,244 (0%) | 0% | 372.5 | 223,476 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 500 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Sale of securities on an exchange or to another person at price $ 705.39 per share. | 03 Oct 2022 | 500 | 19,644 (0%) | 0% | 705.4 | 352,695 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 342.93 per share. | 03 Oct 2022 | 500 | 20,144 (0%) | 0% | 342.9 | 171,465 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 1,100 | 500 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Sale of securities on an exchange or to another person at price $ 577.62 per share. | 01 Sep 2022 | 1,100 | 19,644 (0%) | 0% | 577.6 | 635,382 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 342.93 per share. | 01 Sep 2022 | 1,100 | 20,744 (0%) | 0% | 342.9 | 377,223 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2022 | 1,100 | 1,600 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 342.93 per share. | 01 Aug 2022 | 1,100 | 20,744 (0%) | 0% | 342.9 | 377,223 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Sale of securities on an exchange or to another person at price $ 581.53 per share. | 01 Aug 2022 | 1,100 | 19,644 (0%) | 0% | 581.5 | 639,683 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 342.93 per share. | 01 Jul 2022 | 1,100 | 20,744 (0%) | 0% | 342.9 | 377,223 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2022 | 1,100 | 2,700 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Sale of securities on an exchange or to another person at price $ 587.76 per share. | 01 Jul 2022 | 1,100 | 19,644 (0%) | 0% | 587.8 | 646,536 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 1,100 | 3,800 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 342.93 per share. | 01 Jun 2022 | 1,100 | 20,744 (0%) | 0% | 342.9 | 377,223 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Sale of securities on an exchange or to another person at price $ 669.51 per share. | 01 Jun 2022 | 1,100 | 19,644 (0%) | 0% | 669.5 | 736,461 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Sale of securities on an exchange or to another person at price $ 656.97 per share. | 02 May 2022 | 1,100 | 19,644 (0%) | 0% | 657.0 | 722,667 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 342.93 per share. | 02 May 2022 | 1,100 | 20,744 (0%) | 0% | 342.9 | 377,223 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2022 | 1,100 | 4,900 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2022 | 1,000 | 6,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Sale of securities on an exchange or to another person at price $ 701.82 per share. | 01 Apr 2022 | 1,000 | 19,644 (0%) | 0% | 701.8 | 701,820 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 342.93 per share. | 01 Apr 2022 | 1,000 | 20,644 (0%) | 0% | 342.9 | 342,930 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 342.93 per share. | 01 Mar 2022 | 1,000 | 20,644 (0%) | 0% | 342.9 | 342,930 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 1,000 | 7,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Sale of securities on an exchange or to another person at price $ 615.39 per share. | 01 Mar 2022 | 1,000 | 19,644 (0%) | 0% | 615.4 | 615,390 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Sale of securities on an exchange or to another person at price $ 607.46 per share. | 01 Feb 2022 | 1,000 | 19,644 (0%) | 0% | 607.5 | 607,460 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 342.93 per share. | 01 Feb 2022 | 1,000 | 20,644 (0%) | 0% | 342.9 | 342,930 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2022 | 1,000 | 8,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Sale of securities on an exchange or to another person at price $ 625.00 per share. | 03 Jan 2022 | 1,000 | 19,644 (0%) | 0% | 625 | 625,000 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 342.93 per share. | 03 Jan 2022 | 1,000 | 20,644 (0%) | 0% | 342.9 | 342,930 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 1,000 | 9,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 664.34 per share. | 11 Dec 2021 | 388 | 19,988 (0%) | 0% | 664.3 | 257,764 | Common Stock |
| Regeneron Pharma | Marion McCourt | EVP Commercial | Sale of securities on an exchange or to another person at price $ 653.12 per share. | 11 Dec 2021 | 344 | 19,644 (0%) | 0% | 653.1 | 224,673 | Common Stock |